Owkin is building competitive-intelligence AI agents on K Pro inside AstraZeneca's infrastructure under a three-year licence.

AstraZeneca needed timely, data-rich answers to complex competitive intelligence questions with less manual analysis, within its governance and security standards. Owkin leads end-to-end development of agents on K Pro integrated into AstraZeneca's IT infrastructure and decision workflows. No agent performance metrics are given; the page cites the earlier gBRCA model ruling out about 40% of patients at 93% sensitivity.

Owkin is a French AI company building biology models and the K Pro AI Scientist, working with pharma on drug positioning, trial design and pathology diagnostics.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.